Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (2436)	11/12/1997 4:42:00 PM
From: Vol	Respond to of 23519

Nice work, BP! Not only for Vivus, but for your patients! Practicing without a licence again, eh? <ggggg> vol

To: Bradpalm1 who wrote (2436)	11/12/1997 7:01:00 PM
From: Dan'l Leviton	Respond to of 23519

Bradpalm1, Thanks for the best laugh of the day! Not a sphygmomanometer, Dan'l

To: Bradpalm1 who wrote (2436)	11/12/1997 9:23:00 PM
From: david bell	Read Replies (1) \| Respond to of 23519

I cannot beleive the interest in ED of late in the office related to Viagra pre-marketing. Patient after patient is bringing up ED where as even a year ago it was difficult to get patients to talk. I beleive that we are seeing a bit of a "proscar "type situation developing. Those urologists know the hype of this drug which resulted in many men coming forward with BPH. They were tried on the pill and ended up having TURPS. Lets look at MUSE and Caverject as the TURP as they work.